GAGodrej Agrovet540743Quarterly results

Q2 revenue up 17%, PAT up 22%, EBITDA flat; H1 revenue up 13%

Revenue ₹2,995 cr, up 17% YoY.

By ScoutQuest · Fri 6 Nov 2026, 11:48 AM IST · 2 min read

Q2 FY27 Revenue

₹2,995 cr, up 17% YoY

Q2 FY27 EBITDA

₹222 cr, flat; margin 7.4% vs 8.6%

Q2 FY27 PAT

₹103 cr, up 22%

Headline numbers

Q2 FY27 revenue was ₹2,995 cr, up 17% from ₹2,564 cr a year earlier. EBITDA was flat at ₹222 cr, and the EBITDA margin fell to 7.4% from 8.6%, a 120 bps decline. Profit before tax rose 5% to ₹131 cr and profit after tax rose 22% to ₹103 cr.

For the half year, revenue was ₹5,847 cr, up 13%, while EBITDA at ₹476 cr was down 5%, PBT at ₹299 cr down 4% and PAT at ₹231 cr down 1%. The company described the quarter as strong double-digit revenue growth with earnings resilience in a challenging operating environment.

What drove the quarter

• Animal Nutrition revenue up 14%, segment result up 32% with margin up 90 bps to 6.7%; cattle feed volume up about 8% and layer feed up about 15%
• Oil Palm revenue up 28% on higher CPO (+23%) and PKO (+20%) realisations; fresh fruit bunch volume up about 14%
• Godrej Foods revenue up 8%, adjusted EBITDA up about 12%, margin up 20 bps to 5.8%
• ACI-GAVL, Bangladesh revenue up 32%, PAT up about 20%
• Creamline Dairy revenue up 6%, led by pricing and about 12% higher value-added products

Where the pressure was

• Crop Care revenue up 42% on a low base, but profitability down 23% and margin at 12.6%, on poor cotton herbicide demand and an unfavourable product mix
• Astec LifeSciences revenue down about 3%; the company refers to an EBITDA loss that widened on lower enterprise volumes, reduced realisations and elevated input costs
• Creamline Dairy EBITDA margin down 340 bps to 1.2% on elevated milk procurement, packaging and logistics costs
• Input cost inflation and El Niño-related weather disruption are cited as the margin headwinds

Balance sheet and efficiency

The release notes working capital at 21 days versus 32 days last year, which it calls strong working capital management.

Management view

Managing Director and CEO Sunil Kataria said consolidated revenue grew 17% and PAT rose 22% even as input cost inflation held EBITDA flat. The commentary points to strategic steps: exiting shrimp in Animal Nutrition to focus on profitable segments, Oil Palm plantation expansion and commissioning of the Khammam complex, CPKO refinery and biogas plant, Ashitaka scaling with H1 sales about six times last year, B2C salience in Foods rising to about 38% from about 27%, and value-added products at about 49% of the Dairy portfolio, up from about 44%.

How to read it

The topline is growing faster than profits in the quarter, and the first half shows lower EBITDA and PAT than last year. Segment performance is uneven: Animal Nutrition and Oil Palm are expanding, while Crop Care, Dairy and Astec are weighing on profitability. Readers can judge the balance from the segment figures and the margin trend above.

Investor call

An earnings conference call is scheduled at 16:00 hrs IST on Friday, 6th November 2026; dial-in and registration details are part of the release.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev